Future of Flexibility and Optimization - how do we get more therapies approved and approved faster
Collaboration, especially at the interface between process development and manufacturing technology, will be essential if CGT developers hope to fully realize the extraordinary potential that these therapies carry for our collective future.
How do we achieve more downstream success – all boats rise approach
Flexibility
Integration of all products – not just Sexton but across all manufacturers
Shared manufacturing strategies
Open industry knowledge
Not follow computer universe Mac VS IBM – you had to adopt one ecosystem or the other and the more invested you were in that ecosystem the harder, most expensive it was to switch
Optimization
Decrease costs – decrease AP risk which is key to getting more of these therapies into testing
Decrease safety risks
Sexton Biotechnologies
How are we leading the industry to a brighter future